EUVIMEDSkopri EUVIMED
Crossref

Glucokinase Regulatory Protein Gene Polymorphism as a Predictive Biomarker for Early Renal Injury in Newly Diagnosed Early‐Onset Type 2 Diabetes Mellitus

Rui Zhang, Ping Zhang, Tianhao Ba, Yilin Zhao, Wei Liu, Simin Zhang, Xiantong Zou, Yingying Luo, Wei Deng, Qiuping Wang, Lin Qi, Yufeng Li and 11 more

Diabetes/Metabolism Research and Reviews · 2026-07 · 42 (5)

DOI: 10.1002/dmrr.70197 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, published online on 2026-06-24. Written by Rui Zhang and 22 co-authors. Institution: Peking University People's Hospital, Beijing, China. Major MEDLINE topics: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Polymorphism, Single Nucleotide, Biomarkers. 19 references. Funded by: National Natural Science Foundation of China, Beijing Municipal Science and Technology committee Fund, Beijing Natural Science Foundation.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

Glucokinase regulatory protein gene ( GCKR ) polymorphisms have been linked to progressive renal dysfunction in diabetic populations. However, their role in early renal injury of diabetic kidney disease (DKD) remains unclear. This study aimed to investigate the association between GCKR genetic variants and early renal impairment in newly diagnosed early‐onset type 2 diabetes mellitus (T2DM).

Methods

A total of 337 newly diagnosed early‐onset T2DM patients from a prospective cohort were enroled. Baseline characteristics, estimated glomerular filtration rate (eGFR), and urinary albumin‐to‐creatinine ratio (UACR) were collected. Seven single nucleotide polymorphisms (SNPs) in GCKR were genotyped using ASAMD microarrays. Participants were divided into normal (UACR < 30 mg/g) and elevated albuminuria (UACR ≥ 30 mg/g) groups. Logistic regression and multivariate linear regression were performed to evaluate the relationship between GCKR genotypes and UACR.

Results

The patients had a mean age of 33.25 ± 5.38 years. Median eGFR was 119.33 mL/min/1.73 m 2 , and median UACR was 14.97 mg/g; 107 patients (31.8%) presented with elevated UACR. Carriers of the GCKR rs1260326 T/T genotype exhibited significantly higher median UACR compared with C/T + C/C carriers (22.85 vs. 13.53 mg/g, p = 0.021). The rs1260326 T allele was independently associated with increased UACR under the additive genetic model ( p = 0.003) adjusted for sex, age, body mass index (BMI), glycated haemoglobin (HbA1c), and systolic blood pressure (SBP).

Conclusions

The GCKR rs1260326 T allele is independently associated with early renal injury in newly diagnosed early‐onset T2DM. This genetic variant may serve as a predictive marker for early DKD risk stratification in this high‐risk population.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesPolymorphism, Single NucleotideBiomarkersAdaptor Proteins, Signal TransducingHumansFemaleMaleProspective StudiesAdultGlomerular Filtration RatePrognosisAlbuminuriaGenotypeFollow-Up StudiesCarrier Proteins

Author keywords

GCKRUACRdiabetic kidney diseaseearly‐onset type 2 diabetes

Substances

BiomarkersAdaptor Proteins, Signal TransducingGCKR protein, humanglucokinase regulatory proteinCarrier Proteins

Authors and institutions

  • Peking University People's Hospital, Beijing, China.
  • Beijing Key Laboratory of Innovative Drug and Device Translation in Endocrine and Metabolic Diseases, Beijing, China.
  • Beijing Jishuitan Hospital, Beijing, China.
  • Liangxiang Hospital, Beijing, China.
  • Beijing Yanhua Hospital, Beijing, China.
  • Pinggu District Hospital, Beijing, China.

ORCID profiles: Liyong Zhong, Xueyao Han, Linong Ji

Funding

  • National Natural Science Foundation of China
  • Beijing Municipal Science and Technology committee Fund
  • Beijing Natural Science Foundation
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • 2024 National Clinical Key Specialty Construction Program of China

Cite

APA

Zhang, R., Zhang, P., Ba, T., Zhao, Y., Liu, W., Zhang, S., Zou, X., Luo, Y., Deng, W., Wang, Q., Qi, L., Li, Y., Wang, W., Zhong, L., Huo, L., Li, C., Hao, D., Zhang, Y., Xu, Y., …, & Ji, L. (2026). Glucokinase Regulatory Protein Gene Polymorphism as a Predictive Biomarker for Early Renal Injury in Newly Diagnosed Early‐Onset Type 2 Diabetes Mellitus. Diabetes/Metabolism Research and Reviews, 42(5). https://doi.org/10.1002/dmrr.70197

Vancouver

Zhang R, Zhang P, Ba T, Zhao Y, Liu W, Zhang S, et al. Glucokinase Regulatory Protein Gene Polymorphism as a Predictive Biomarker for Early Renal Injury in Newly Diagnosed Early‐Onset Type 2 Diabetes Mellitus. Diabetes/Metabolism Research and Reviews. 2026;42(5). doi:10.1002/dmrr.70197

BibTeX
@article{Zhang2026,
  author = {Zhang, Rui and Zhang, Ping and Ba, Tianhao and Zhao, Yilin and Liu, Wei and Zhang, Simin and Zou, Xiantong and Luo, Yingying and Deng, Wei and Wang, Qiuping and Qi, Lin and Li, Yufeng and Wang, Wenbo and Zhong, Liyong and Huo, Lili and Li, Chunxia and Hao, Dejun and Zhang, Yajing and Xu, Yan and Wang, Fang and Han, Xueyao and Ren, Qian and Ji, Linong},
  title = {Glucokinase Regulatory Protein Gene Polymorphism as a Predictive Biomarker for Early Renal Injury in Newly Diagnosed Early‐Onset Type 2 Diabetes Mellitus},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {5},
  doi = {10.1002/dmrr.70197}
}
Start for free →